Walleye Trading
XBI icon

Walleye Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Walleye Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Sell
92,166
-195,555
-68% -$26.4M 0.02% 758
2026
Q1 		$36.8M Buy
287,721
+188,401
+190% +$23.5M 0.06% 311
2025
Q4 		$12.1M Buy
99,320
+68,081
+218% +$7.81M 0.02% 832
2025
Q3 		$3.13M Sell
31,239
-24,629
-44% -$2.22M ﹤0.01% 1530
2025
Q2 		$4.63M Sell
55,868
-20,972
-27% -$1.67M 0.01% 1248
2025
Q1 		$6.23M Buy
+76,840
New +$6.87M 0.01% 961
2024
Q3 		– Sell
-512
Closed -$50.3K – 4647
2024
Q2 		$47.5K Sell
512
-38,098
-99% -$3.42M ﹤0.01% 3608
2024
Q1 		$3.66M Sell
38,610
-30,539
-44% -$2.83M 0.01% 1334
2023
Q4 		$6.17M Sell
69,149
-71,336
-51% -$5.3M 0.01% 1118
2023
Q3 		$10.3M Buy
140,485
+85,150
+154% +$6.8M 0.03% 676
2023
Q2 		$4.6M Sell
55,335
-128,754
-70% -$10.8M 0.01% 1013
2023
Q1 		$14M Buy
184,089
+179,239
+3,696% +$14.9M 0.03% 498
2022
Q4 		$403K Sell
4,850
-39,520
-89% -$3.2M ﹤0.01% 2994
2022
Q3 		$3.52M Buy
+44,370
New +$3.74M 0.01% 1277
2022
Q2 		– Sell
-46,021
Closed -$3.45M – 5754
2022
Q1 		$4.14M Buy
+46,021
New +$4.25M 0.01% 1119
2021
Q1 		– Sell
-14,075
Closed -$2.11M – 5378
2020
Q4 		$1.98M Sell
14,075
-8,545
-38% -$1.09M 0.01% 1395
2020
Q3 		$2.52M Buy
22,620
+21,319
+1,639% +$2.39M 0.01% 971
2020
Q2 		$146K Buy
1,301
+786
+153% +$77.4K ﹤0.01% 3293
2020
Q1 		$40K Buy
+515
New +$45.6K ﹤0.01% 3485
2019
Q4 		– Sell
-4,029
Closed -$349K – 4682
2019
Q3 		$307K Buy
+4,029
New +$335K ﹤0.01% 2563
2019
Q1 		– Sell
-13,913
Closed -$1.18M – 4854
2018
Q4 		$998K Buy
+13,913
New +$1.12M 0.01% 1715
2018
Q1 		– Sell
-1,895
Closed -$173K – 4852
2017
Q4 		$161K Sell
1,895
-1,700
-47% -$142K ﹤0.01% 3599
2017
Q3 		$311K Buy
+3,595
New +$288K ﹤0.01% 2895
2017
Q2 		– Sell
-8,847
Closed -$627K – 5000
2017
Q1 		$613K Buy
+8,847
New +$594K ﹤0.01% 2066

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Walleye Trading's XBI Position: Q2 2026 in Review

Walleye Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 68% in Q2 2026, selling an estimated $26.4M and leaving 92,166 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #758.

Walleye Trading first reported a position in XBI in Q1 2017 and has held it in 24 quarters since. The position peaked at $36.8M in Q1 2026. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Walleye Trading held 92,166 shares of State Street SPDR S&P Biotech ETF worth $14.6M as of Q2 2026.
  • Walleye Trading sold 195,555 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $26.4M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Walleye Trading's portfolio in Q2 2026, its #758 holding.
  • Walleye Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 24 quarters since.
  • Walleye Trading's State Street SPDR S&P Biotech ETF position peaked at $36.8M in Q1 2026.
  • 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.